eShowcase: ClearTrial 2.0
Web-based dashboard places clinical trial designers squarely in the driver's seat
Web-based dashboard places clinical trial designers squarely in the driver's seat
ClearTrial, LLC (Oakbrook Terrace, IL) has released version 2.0 of its clinical trial operations planning software to help biopharm companies and CROs plan, budget, and optimize the operational design of clinical trials.
The heart of this latest version is a Web-based "dashboard" that offers a view of monthly budgets, accruals forecasts, study metrics, cycle-time dates, costs, and FTE/resource requirements. Also new is support for multiple outsourcing strategies, full-service outsourcing, hybrid studies, staff augmentation, and internal studies.
Other adornments to this version include the ability to compare cost and timelines between internal studies and outsourced ones, as well as assign study tasks to multiple service providers by function or country. Collaborative planning is also now possible between departments, business units, and strategic partners.
ClearTrial 2.0 is a J2EE-compliant, native Web-based application running over an Oracle database.
ClearTrial, LLC, (630) 424-1601, www.cleartrial.com
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Full Phase IIIb BATURA Trial Results Show Airsupra Cuts Severe Exacerbations by 47% in Mild Asthma
May 20th 2025Results from the pivotal BATURA trial show that Airsupra (albuterol/budesonide) significantly outperformed albuterol monotherapy in reducing severe asthma exacerbations and systemic corticosteroid exposure, reinforcing its role as a next-generation, anti-inflammatory rescue therapy for mild asthma patients.
